Extensive lanthanum deposition in the gastric mucosa: The first histopathological report

@article{Makino2015ExtensiveLD,
  title={Extensive lanthanum deposition in the gastric mucosa: The first histopathological report},
  author={Mutsuki Makino and Kenji Kawaguchi and Hisashi Shimojo and Hironori Nakamura and Masaki Nagasawa and Ryo Kodama},
  journal={Pathology International},
  year={2015},
  volume={65}
}
Lanthanum carbonate is one of the new phosphate binders used for the treatment of hyperphosphatemia in patients with chronic kidney disease. It is poorly absorbed from the gastrointestinal tract, forms insoluble complexes within the lumen, and prevents the absorption of dietary phosphate. A 63‐year‐old female with a 7‐year history of peritoneal dialysis, who was treated with lanthanum carbonate for four years, underwent endoscopic submucosal dissection for intramucosal gastric cancer. Resected… Expand
Gastric lanthanosis (lanthanum deposition) in dialysis patients treated with lanthanum carbonate
TLDR
Clinopathological features of gastric lanthanosis were mucosal high‐density linear appearance by CT, reflective bright‐white spots by gastroscopy, eosinophilic histiocytes occasionally phagocytizing foreign materials by histology, and numerous electron‐dense particles in the histi cells. Expand
Review of the diagnosis of gastrointestinal lanthanum deposition
TLDR
This review provides an overview of gastroduodenal lanthanum deposition and focuses on disease’s endoscopic, radiological, and histological features, prevalence, and outcome, by reviewing relevant clinical studies, case reports, and basic research findings, to better understand the endoscopic manifestation of gastrointestinal lanthanums deposition. Expand
Lanthanum-Induced Mucosal Alterations in the Stomach (Lanthanum Gastropathy): a Comparative Study Using an Animal Model
TLDR
Oral administered Lanthanum (La) carbonate can induce mucosal injury, designated here as La gastropathy, which may alter the local environment and result in La deposition in the gastric mucosa, thereby potentially inducing abnormal cell proliferation or neoplastic lesions. Expand
Lanthanum carbonated-associated injury to the small intestine
TLDR
The differential diagnosis of gastrointestinal histiocytosis should include lanthanum carbonate medication-associated injury in renal failure patients, further expanding the list of medications associated with gastrointestinal tract injury in patients with renal disease. Expand
Lanthanum Deposition Is Frequently Observed in the Gastric Mucosa of Dialysis Patients With Lanthanum Carbonate Therapy
TLDR
To obtain a more precise incidence rate of lanthanum deposition based on pathologic investigation, 153 pathological specimens of the digestive tract were surveyed from 103 dialysis patients, including 19 patients treated with LC from May 2009 to May 2015 in a single institute. Expand
Lanthanum Deposition in the Gastroduodenal Mucosa of Dialysis Patients.
TLDR
The amount of La deposition in the gastroduodenal mucosa is correlated with the total dose of LC administration, and La deposition is almost consistently observed in LC-treated dialysis patients. Expand
Gastric mucosal status susceptible to lanthanum deposition in patients treated with dialysis and lanthanum carbonate.
TLDR
The evaluation of the gastric mucosal status seems to be important to predict lanthanum deposition when Lanthanum carbonate is administered for patients with chronic kidney disease treated with dialysis. Expand
Lanthanum deposition in the gastrointestinal mucosa and regional lymph nodes in dialysis patients: Analysis of surgically excised specimens and review of the literature.
TLDR
More detailed histopathological findings in the gastroduodenal mucosa and regional lymph nodes in three patients with gastric cancer are described and lanthanum accumulation was noted in the duodenals and the antral and body mucosae of the gastric lesser curvature. Expand
Correlation of lanthanum dosage with lanthanum deposition in the gastroduodenal mucosa of dialysis patients
TLDR
Investigation of gastrointestinal biopsies from 112 dialysis patients found 15 cases of histiocytic aggregation with crystalloids and one case of duodenitis with histiocyte aggregation without crystalloids in the 30 patients treated with La carbonate, revealing that the daily and total doses of La carbonates showed statistically significant correlations with La deposition. Expand
Gastropathy associated with lanthanum phosphate deposition that was endoscopically tracked for 3 years. A case report
TLDR
Scanning electron microscopy-energy dispersive X-ray spectroscopy (SEM-EDX) revealed that the presence of the deposits containing phosphorus and lanthanum in the gastric mucosa was confirmed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure.
TLDR
The kinetics of lanthanum in the Liver are consistent with a transcellular transport pathway, with higher levels in the liver of uremic rats due to higher intestinal absorption, and there is an increased gastrointestinal permeability or absorption of oral lanthanums in uremia. Expand
Lanthanum deposition in a dialysis patient.
  • R. Davis, J. L. Abraham
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2009
TLDR
Previously unreported La deposition visible by light microscopy and confirmed by scanning electron microscopy with energy dispersive x-ray spectroscopy in a mesenteric lymph node at autopsy of a 38-year-old female ESRD patient 3 years following LaCO(3) administration are observed. Expand
Clinical Pharmacokinetics of the Phosphate Binder Lanthanum Carbonate
TLDR
The pharmacokinetic investigations of lanthanum carbonate formed an important part of the stringent premarketing safety assessment process and have been influential in reassuring both regulators and physicians that the agent can be used safely and effectively in this vulnerable dialysis population. Expand
Progressive accumulation of lanthanum in the liver of normal and uremic rats.
TLDR
La accumulates in tissues, most strikingly in the liver, and renal failure accelerates the accumulation, while this was a relatively short-term study, La accumulation increased in a time-dependent manner. Expand
Lanthanum carbonate: a postmarketing observational study of efficacy and safety.
TLDR
In hemodialysis patients, lanthanum carbonate does not seem to be involved in metabolic bone disease, and is effective and well tolerated, provided that recipients do not have preexisting liver disease. Expand
Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration.
TLDR
The oral administration of lanthanum carbonate to normal rats leads to a more than 10-fold increase of tissue La content in at least some organs, including the liver, lung, and kidney, which is further enhanced by the uremic state. Expand
Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.
TLDR
It is hypothesized that long-term persistence and slow release of Gd(3+) from bone stores can be a cause for concern of GD-associated toxicity with long latency, and may explain the variable latency of onset of NSF. Expand
Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up.
  • G. Spasovski, A. Šikole, +7 authors P. D'Haese
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2006
TLDR
Bone deposition after 1 year of treatment with LC is low and there is a slow release of lanthanum from its bone deposits 2 years after the discontinuation of the treatment and no association with aluminium-like bone toxicity. Expand
Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents
TLDR
A correlation between the complex stability of G BCAs and the amount of residual Gd in the skin up to a year after application of GBCAs is observed. Expand
Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases.
TLDR
The data indicate that various gastrointestinal abnormalities commonly occur in patients with endstage renal disease despite uremia control by hemodialysis, however, the observed abnormalities are different from those reported in untreated Uremia. Expand
...
1
2
...